CARDARINE NORDIC FUSION
104,00 €
| Use in sports | Banned by major sports organizations |
|---|---|
| Formula | C21H18F3NO3S2 |
| Side effects | Potential carcinogenic effects, liver toxicity, possible development of other cancers |
| Effects | Increased endurance, fat loss, improved lipid profile |
| Dosage (sports) | 10-20 mg per day |
| Dosage (medical) | Not medically approved for therapeutic use |
| Half-life | 16-24 hours |
| Main action | Enhances fatty acid metabolism |
| Substance class | PPARОґ receptor agonist |
| Chemical name | {4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methyl)sulfanyl]-2-methylphenoxy}acetic acid |
| Storage conditions | Store at room temperature, protect from light and moisture |
| Trade name | Not available as a legally approved drug |
| Blood pressure | No significant impact |
| Also known as | GW-501516, Cardarine |
| Lab Test | Detection in blood and urine tests |
| Hepatotoxicity | Yes, potential liver toxicity |
| Water Retention | No |
| Raw Material | Cardarine |
| Manufacturer | NORDIC FUSION |
| Packing | 30 tabs (20 mg/tab) |
Reviews
There are no reviews yet.